Filter News
Area of Research
- (-) Isotopes (3)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (2)
- Biology and Environment (38)
- Clean Energy (35)
- Climate and Environmental Systems (4)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (2)
- Fusion and Fission (10)
- Fusion Energy (8)
- Materials (20)
- Materials for Computing (2)
- Mathematics (1)
- National Security (14)
- Neutron Science (12)
- Quantum information Science (2)
- Supercomputing (23)
News Topics
- (-) Biomedical (4)
- (-) Environment (1)
- (-) Fusion (2)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (6)
- Bioenergy (1)
- Climate Change (1)
- Computer Science (2)
- Decarbonization (1)
- Energy Storage (1)
- Irradiation (1)
- Isotopes (12)
- Materials (2)
- Materials Science (2)
- Molten Salt (3)
- Neutron Science (3)
- Nuclear Energy (18)
- Physics (1)
- Security (1)
- Space Exploration (6)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
As scientists study approaches to best sustain a fusion reactor, a team led by Oak Ridge National Laboratory investigated injecting shattered argon pellets into a super-hot plasma, when needed, to protect the reactor’s interior wall from high-energy runaway electrons.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.